NCT03828149

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Novus Therapeutics, Inc · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

Detailed description

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

Conditions

• Healthy Adults

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Drug:OP0201	Drug: OP0201
COMBINATION_PRODUCT	Drug: Placebo	Drug: Placebo

Timeline

• Start date: 2019-02-08
• Primary completion: 2019-03-07
• Completion: 2019-03-07
• First posted: 2019-02-04
• Last updated: 2019-12-30
• Results posted: 2019-12-30

Locations

1 site across 1 country: Germany

Regulatory

• FDA-regulated drug study